Leukemia Research
Volume 28, Issue 8 , Pages 791-803, August 2004

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression

  • Azra Raza

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-312-563-4500; fax: +1-312-563-4170.
    • ,
  • Silvia Buonamici

      Affiliations

    • Department of Pathology, University of Illinois, Chicago, IL, USA
    • ,
  • Laurie Lisak

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Sarah Tahir

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Donglan Li

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Mehnaz Imran

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Nusrat Ijaz Chaudary

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Hassan Pervaiz

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • J.Alejandro Gallegos

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • M.Imran Alvi

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Muhammad Mumtaz

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Sefer Gezer

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Parameswaran Venugopal

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Poluru Reddy

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Naomi Galili

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Anna Candoni

      Affiliations

    • Section of Myeloid Diseases and MDS Center, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, 2242 West Harrison Street, Suite 108, Chicago, IL 60612-3515, USA
    • ,
  • Jack Singer

      Affiliations

    • Cell Therapeutics Inc., Seattle, Washington, USA
    • ,
  • Giuseppina Nucifora

      Affiliations

    • Department of Pathology, University of Illinois, Chicago, IL, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(03)00417-X

doi:10.1016/j.leukres.2003.11.018

Leukemia Research
Volume 28, Issue 8 , Pages 791-803, August 2004

Article Tools

* Image Usage & Resolution